Stricter ioPTH criterion for successful parathyroidectomy in stage III CKD patients with primary hyperparathyroidism

被引:7
作者
Liu, Sophia N. [1 ]
Yusufali, Ali H. [1 ]
Mao, Melissa L. [1 ]
Khan, Zahra F. [1 ]
Farra, Josefina C. [1 ]
Lew, John I. [1 ]
机构
[1] Univ Miami, Leonard M Miller Sch Med, Div Endocrine Surg, DeWitt Daughtry Family Dept Surg, 1120 NW 14th St,Clin Res Bldg 410, Miami, FL 33136 USA
关键词
MANAGEMENT; GUIDELINES; EQUATION; SURGERY; DISEASE;
D O I
10.1016/j.surg.2018.05.010
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: The effects of underlying renal insufficiency on intraoperative parathormone monitoring during parathyroidectomy (PTX) for primary hyperparathyroidism remain unclear. This study evaluates operative outcomes in patients undergoing parathyroidectomy using classic or stricter >50% intraoperative parathormone decrease criterion for primary hyperparathyroidism with mild or moderate renal insufficiency. Methods: A retrospective review of prospectively collected data in 577 patients undergoing parathyroidectomy guided by intraoperative parathormone monitoring for primary hyperparathyroidism was performed. Patients were stratified by stages I to III of chronic kidney disease; those with overt secondary hyperparathyroidism (chronic kidney disease stages IV and V) were excluded. Patients were further subdivided into subgroups based on the classic criterion of a >50% intraoperative parathormone decrease and a stricter criterion of a >50% intraoperative parathormone decrease e to a normal range (<65 pg/mL). Long-term operative outcomes were compared across the 3 chronic kidney disease groups. Results: Of 577 patients, 38% (221) had normal renal function or stage I chronic kidney disease, 44% (251) had stage 11 chronic kidney disease, and 18% (105) had stage III chronic kidney disease. In stages I and II chronic kidney disease patients, there were no differences in operative success, failure, recurrence, bilateral neck exploration, and multiglandular disease between classic and stricter criterion groups. In contrast, in stage Ill chronic kidney disease patients, operative success was greater using the stricter intraoperative parathormone criterion than the classic intraoperative parathormone criterion (100% vs 92%, respectively, P < .05). No other outcome differences were identified between classic and stricter intraoperative parathormone criterion subgroups in stage III chronic kidney disease patients. Conclusion: In patients with primary hyperparathyroidism and concurrent stage III chronic kidney disease, a stricter criterion of a >50% intraoperative parathormone decrease to a normal range should be used for successful parathyroidectomy. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:1306 / 1310
页数:5
相关论文
共 24 条
  • [1] Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Fourth International Workshop
    Bilezikian, John P.
    Brandi, Maria Luisa
    Eastell, Richard
    Silverberg, Shonni J.
    Udelsman, Robert
    Marcocci, Claudio
    Potts, John T., Jr.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (10) : 3561 - 3569
  • [2] Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: Which criterion is the most accurate?
    Carneiro, DM
    Solorzano, CC
    Nader, MC
    Ramirez, M
    Irvin, GL
    [J]. SURGERY, 2003, 134 (06) : 973 - 979
  • [3] Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca2+ set-point in patients with primary hyperparathyroidism
    Cetani, F
    Picone, A
    Cerrai, P
    Vignali, E
    Borsari, S
    Pardi, E
    Viacava, P
    Naccarato, AG
    Miccoli, P
    Kifor, O
    Brown, EM
    Pinchera, A
    Marcocci, C
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (12) : 4789 - 4794
  • [4] What is the link between nonlocalizing sestamibi scans, multigland disease, and persistent hypercalcemia? A study of 401 consecutive patients undergoing parathyroidectomy
    Chiu, Bill
    Sturgeon, Cord
    Angelos, Peter
    [J]. SURGERY, 2006, 140 (03) : 418 - 422
  • [5] Intraoperative parathyroid hormone measurement in patients with secondary hyperparathyroidism
    Chou, FF
    Lee, CH
    Chen, JB
    Hsu, KT
    Sheen-Chen, SM
    [J]. ARCHIVES OF SURGERY, 2002, 137 (03) : 341 - 344
  • [6] Elevated parathyroid hormone levels after successful parathyroidectomy for primary hyperparathyroidism: a clinical review
    de la Plaza Llamas, Roberto
    Ramia Angel, Jose Manuel
    Arteaga Peralta, Vladimir
    Garcia Amador, Cristina
    Lopez Marcano, Aylhin Joana
    Medina Velasco, Anibal Armando
    Gonzalez Sierra, Begona
    Manuel Vazquez, Alba
    Latorre Fragua, Raquel Aranzazu
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2018, 275 (03) : 659 - 669
  • [7] Parathyroid histopathology: Is it of any value today?
    Elliott, Danielle D.
    Monroe, Douglas P.
    Perrier, Nancy D.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2006, 203 (05) : 758 - 765
  • [8] Predictors of intra-operative parathyroid hormone decline in subjects operated for primary hyperparathyroidism by minimally invasive parathyroidectomy
    Gannage-Yared, M. -H.
    Abboud, B.
    Amm-Azar, M.
    Saab, A.
    Khalife, S.
    Halaby, G.
    Atallah, C.
    Medlej, R.
    Jambart, S.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2009, 32 (02) : 160 - 164
  • [9] Pathophysiology of parathyroid hyperplasia in chronic kidney disease: preclinical and clinical basis for parathyroid intervention
    Goto, Shunsuke
    Komaba, Hirotaka
    Fukagawa, Masafumi
    [J]. CLINICAL KIDNEY JOURNAL, 2008, 1 : III2 - III8
  • [10] Progress in the operative management of sporadic primary hyperparathyroidism over 34 years
    Irvin, GL
    Carneiro, DM
    Solorzano, CC
    [J]. ANNALS OF SURGERY, 2004, 239 (05) : 704 - 708